Bolt Biotherapeutics, Inc. (BOLT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$36.11M | +50.6% |
| 2024 | -$73.05M | +4.1% |
| 2023 | -$76.20M | +15.6% |
| 2022 | -$90.32M | +2.7% |
| 2021 | -$92.79M | -88.7% |
| 2020 | -$49.18M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$36.11M | +50.6% |
| 2024 | -$73.05M | +4.1% |
| 2023 | -$76.20M | +15.6% |
| 2022 | -$90.32M | +2.7% |
| 2021 | -$92.79M | -88.7% |
| 2020 | -$49.18M | — |